Skip to main content
. 2022 Jun 29;9:924787. doi: 10.3389/fcvm.2022.924787

Table 2.

Differences in myocardial glucose metabolic rate and insulin sensitivity of subjects with T2DM according to metabolic syndrome compared to control subjects.

Control group
(n = 10)
T2DM Control vs. T2DM non-MetS Control vs. T2DM MetS T2DM Non-MetS vs. T2DM MetS
Non-MetS
(n = 6)
MetS
(n = 19)
P-value P-value§ P-value P-value§ P-value P-value§
Insulin-stimulated glucose disposal (mg/min x Kg FFM) 13.01 ± 8.53 2.91 ± 1.54 3.06 ± 1.7 <0.0001 0.01 <0.0001 0.008 0.6
Myocardial MRGlu (μmol/min/100 g) 32.9 ± 9.7 25.15 ± 4.92 10.5 ± 9.04 0.04 0.03 <0.0001 <0.0001 0.001 0.01
LAD Myocardial MRGlu (μmol/min/100 g) 32.41 ± 8.79 23.2 ± 5.6 10.03 ± 9.6 0.04 0.02 <0.0001 <0.0001 0.003 0.04
RCA Myocardial MRGlu (μmol/min/100 g) 33.69 ± 12.38 26.59 ± 4.7 9.9 ± 8.00 0.05 0.04 <0.0001 <0.0001 0.002 0.001
LCX Myocardial MRGlu (μmol/min/100 g) 32.79 ± 9.1 26.3 ± 5.7 11.7 ± 9.6 0.05 0.04 <0.0001 <0.0001 0.002 0.02

Continous data are expressed as means ± SD. Comparisons between the groups were performed using a general linear model. MRGlu, glucose metabolic rate; LAD, left anterior descending; LCX, left circumflex; RCA, right coronary artery. §P-values refer to results after analyses with adjustment for age and gender.